+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Renal Replacement Therapy Market - Global Forecast to 2030- Product Image
Continuous Renal Replacement Therapy Market - Global Forecast to 2030- Product Image
Sale

Continuous Renal Replacement Therapy Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5896406
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Continuous Renal Replacement Therapy Market grew from USD 15.49 billion in 2024 to USD 16.85 billion in 2025. It is expected to continue growing at a CAGR of 8.58%, reaching USD 25.39 billion by 2030.

Continuous Renal Replacement Therapy (CRRT) has emerged as an essential lifeline for critically ill patients experiencing acute kidney injury and multi-organ failure. Growing clinical adoption of CRRT reflects its capacity to provide hemodynamic stability, precise fluid removal, and superior solute clearance compared to intermittent dialysis. The procedure’s continuous nature allows for gradual toxin elimination, reducing the risk of rapid fluid shifts that can jeopardize patient stability in intensive care settings.

This executive summary delves into the evolving dynamics of the CRRT market, examining the regulatory landscape, emerging technologies, and shifting clinical protocols that are reshaping the field. It highlights the impact of upcoming tariff revisions, key segmentation drivers, regional variations, and competitive strategies. By offering strategic insights and actionable recommendations, this report equips healthcare decision-makers, industry leaders, and investment stakeholders with the knowledge required to navigate market complexities and deliver improved patient outcomes.

Transformative Shifts in the CRRT Market

Over the past decade, CRRT has undergone transformative shifts driven by continuous innovation in membrane technologies, automation features, and therapy modalities. High-efficiency membranes with enhanced biocompatibility have reduced complications, while the integration of digital monitoring and AI-driven analytics is optimizing treatment protocols in real time. Portable dialysis machines now offer critical care teams greater flexibility, enabling therapy initiation at bedside and even in resource-limited settings.

Moreover, an increasing focus on adsorbent approaches and pump-assisted systems is expanding the therapeutic toolbox for acute kidney injury management and multi-organ support. Gravity feed applications have improved cost-effectiveness in regions with limited infrastructure, while advanced high-flux dialyzers are gaining traction for severe toxin removal. In parallel, therapy personalization based on patient group characteristics-from neonatal to geriatric cohorts-is enhancing safety profiles and clinical efficacy.

These shifts collectively signal a more adaptive, patient-centric approach to CRRT, fostering collaboration between device manufacturers, healthcare providers, and regulatory agencies.

Cumulative Impact of the 2025 U.S. Tariff Adjustments

As of January 2025, revamped United States tariffs on imported medical devices have introduced notable cost pressures across the CRRT supply chain. Tariff increases on dialysis machines and accessories-particularly high-precision pressure monitors and composite membrane materials-have raised landed costs by up to 12%. For companies reliant on offshore manufacturing, these adjustments have compressed margins and necessitated pricing realignments.

In response, several global suppliers are sourcing components domestically or relocating final assembly to U.S.-based facilities. This nearshoring trend mitigates exposure to import duties but requires significant capital investment and supply chain reengineering. Meanwhile, distributors and hospitals confront higher procurement expenses, prompting negotiations for volume discounts and service bundling to offset incremental costs.

The cumulative effect of these tariff changes is accelerating strategic partnerships between device innovators and contract manufacturers within the United States. Such collaborations aim to streamline production, ensure compliance with regulatory quality standards, and preserve competitive price points in a market increasingly sensitive to budgetary constraints.

Key Segmentation Insights Across CRRT Dimensions

A nuanced segmentation analysis reveals divergent growth drivers and adoption patterns across multiple CRRT dimensions. Based on Product Type, the market encompasses Accessories-ranging from composite membranes to lines and tubes-and further subdivided filters and pressure monitors, flat plate monitors and hollow-fiber filters, as well as solution containers; Dialyzers with high-flux and low-flux variants; and Machines available in portable and stationary formats. When assessed by Therapy Type, continuous venovenous hemodiafiltration, continuous venovenous hemodialysis, continuous venovenous hemofiltration, and slow continuous ultrafiltration each address specific solute clearance and fluid removal requirements, influencing device selection and consumable usage.

Evaluating End-User adoption patterns uncovers that hospitals-both private and public-remain the predominant settings for CRRT deployment, with ambulatory surgical centers and specialty clinics gradually integrating on-demand service models. Home care settings present an emerging opportunity, especially for long-duration treatments supported by portable dialysis machines. Insights based on Patient Group show adult cohorts, including young adults and middle-aged individuals, account for the majority of cases, while geriatric and pediatric segments-including neonatal and infant patients-drive demand for customizable therapy protocols and miniaturized devices.

Technological segmentation highlights the rise of adsorbent approaches-both recyclable and single-use adsorbents-as well as gravity feed applications, high-efficiency membranes, and pump-assisted continuous renal replacement therapy systems. Application-based analysis underscores acute kidney injury management as the primary use case, followed by multi-organ failure, management of electrolyte imbalances, and septic shock treatment. Lastly, treatment frequency and mode of service segmentation differentiate intermittent therapy sessions from long- and short-duration treatments, and fixed schedule services from on-demand dialysis offerings, guiding product innovation and service delivery strategies.

Key Regional Insights Shaping Market Dynamics

Regionally, the Americas maintain leadership in CRRT adoption, propelled by high healthcare expenditure, advanced hospital networks, and robust reimbursement frameworks. The United States, in particular, accounts for a significant share of global device installations and consumable usage. Transitioning across the pond, the Europe, Middle East & Africa region exhibits heterogeneous growth, with Western European countries driving innovation through stringent regulatory compliance and tenders, while emerging markets in the Middle East and Africa prioritize cost-effective gravity feed and portable solutions to expand access.

Meanwhile, the Asia-Pacific region is witnessing rapid uptake, underpinned by increasing critical care capacity, government initiatives to bolster renal care infrastructure, and growing public-private partnerships. Countries such as China, Japan, and Australia are early adopters of advanced high-flux dialyzers and AI-enhanced monitoring platforms, whereas India and Southeast Asian markets emphasize scalable, pump-assisted systems that can operate reliably in constrained environments. These regional nuances inform go-to-market strategies and localization efforts for device manufacturers and service providers.

Key Company Profiles and Competitive Strategies

The competitive landscape features a blend of global conglomerates, specialized medtech innovators, and emerging disruptors. Industry titans such as B. Braun SE and Baxter International Inc. leverage extensive portfolios spanning machines, dialyzers, and accessory lines, while Fresenius Medical Care AG & Co. KGaA remains prominent through integrated therapy platforms and global service networks. Medtronic PLC and Thermo Fisher Scientific Inc. harness their broader diagnostics and device expertise to introduce advanced monitoring and automation modules.

Japan-based leaders like Asahi Kasei Medical Co. Ltd. and Nikkiso Co. Ltd. focus on membrane technology and compact dialysis units, whereas Toray Medical Co. Ltd. by Toray Industries Inc. excels in high-efficiency membranes and pump-assisted systems. European specialists including DIAMED Medizintechnik GmbH, Biomedica Medizinprodukte GmbH, Infomed SA, Joline GmbH & Co. KG, and Sphingotec GmbH drive innovation in filter design and adsorbent materials. In the emerging cohort, Quanta Dialysis Technologies Limited, Nuwellis Inc., and Miromatrix Medical Inc. challenge incumbents with modular, patient-centric solutions.

Complementing this array are players such as Anjue Medical Equipment Co. Ltd., Braun & Co. Limited, CytoSorbents Corporation, Medites Pharma spol. s.r.o, Nextkidney B.V., Ningbo Tianyi Medical Devices Co. Ltd., Nipro Corporation, SB-KAWASUMI LABORATORIES Inc., Shionogi & Company Limited, SWS Hemodialysis Care Co. Ltd., and DIAMED Medizintechnik GmbH-all pursuing strategic partnerships, product life-cycle management, and regulatory approvals to reinforce market positions.

Actionable Recommendations for CRRT Market Leaders

Industry leaders must prioritize a multifaceted strategy to capitalize on evolving CRRT dynamics. First, investing in R&D for next-generation membranes and adsorbent materials will drive differentiation, particularly in high-flux and pump-assisted technologies. Second, expanding domestic manufacturing capabilities or partnering with local contract manufacturers can alleviate tariff-related cost burdens and strengthen supply chain resilience.

Furthermore, companies should deploy digital platforms offering real-time data analytics, remote monitoring, and predictive maintenance to enhance therapy safety and efficiency. Strategic collaborations with healthcare providers and academic institutions can accelerate clinical validation of novel therapies and support regulatory submissions. In parallel, tailoring product portfolios to address specific regional needs-such as gravity feed systems for resource-limited settings and on-demand services for ambulatory centers-will unlock new revenue streams.

Lastly, cultivating services around education, training, and telehealth support will deepen customer engagement and drive recurring consumable sales. By integrating commercial, clinical, and technological initiatives, industry leaders can reinforce market leadership and deliver sustainable growth.

Conclusion: Charting the Future of CRRT

The CRRT market stands at the intersection of clinical necessity and technological innovation. As membrane science, automated systems, and digital health converge, stakeholders have an unprecedented opportunity to redefine acute renal care. Navigating tariff fluctuations, regional disparities, and shifting therapy protocols requires agile strategies grounded in deep market intelligence.

By harnessing advanced materials, localizing production, and embedding digital solutions into therapy workflows, device manufacturers and service providers can enhance patient outcomes while safeguarding profitability. Strategic segmentation-aligned with end-user preferences, patient demographics, and application requirements-will drive targeted investments and product launches. Ultimately, a cohesive approach that bridges R&D, supply chain optimization, and stakeholder partnerships will determine the next frontier of CRRT excellence.

Market Segmentation & Coverage

This research report categorizes the Continuous Renal Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Accessories
    • Composite Membranes
    • Filters And Pressure Monitors
      • Flat Plate Monitors
      • Hollow-Fiber Filters
    • Lines And Tubes
    • Solution Containers
  • Dialyzers
    • High-Flux Dialyzers
    • Low-Flux Dialyzers
  • Machines
    • Portable Dialysis Machines
    • Stationary Dialysis Machines
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Slow Continuous Ultrafiltration (SCUF)
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Specialty Clinics
  • Adult Patients
    • Middle Aged
    • Young Adults
  • Geriatric Patients
  • Pediatric Patients
    • Infant
    • Neonatal
  • Adsorbent Approaches
    • Recyclable Adsorbents
    • Single-Use Adsorbents
  • Gravity Feed Applications
  • High-Efficiency Membranes
  • Pump Assisted Continuous Renal Replacement Therapy (PA-CRRT)
  • Acute Kidney Injury Management
  • Management Of Electrolyte Imbalances
  • Multi-Organ Failure
  • Septic Shock
  • Intermittent Therapy Sessions
  • Long-Duration Treatments
  • Short-Duration Treatments
  • Fixed Scheduled Services
  • On-Demand Dialysis Services

This research report categorizes the Continuous Renal Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Continuous Renal Replacement Therapy Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Anjue Medical Equipment Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun SE
  • Baxter International Inc.
  • Biomedica Medizinprodukte GmbH
  • Braun & Co. Limited
  • CytoSorbents Corporation
  • DIAMED Medizintechnik GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Infomed SA
  • Joline GmbH & Co. KG
  • Medites Pharma spol. s.r.o
  • Medtronic PLC
  • Miromatrix Medical Inc.
  • Nextkidney B.V.
  • Nikkiso Co., Ltd.
  • Ningbo Tianyi Medical Devices Co., Ltd.
  • Nipro Corporation
  • Nuwellis, Inc.
  • Quanta Dialysis Technologies Limited
  • SB-KAWASUMI LABORATORIES, INC.
  • Shionogi & Company, Limited
  • Sphingotec GmbH
  • SWS Hemodialysis Care Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Toray Medical Co., Ltd. by Toray Industries, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Continuous Renal Replacement Therapy Market, by Product Type
8.1. Introduction
8.2. Accessories
8.2.1. Composite Membranes
8.2.2. Filters And Pressure Monitors
8.2.2.1. Flat Plate Monitors
8.2.2.2. Hollow-Fiber Filters
8.2.3. Lines And Tubes
8.2.4. Solution Containers
8.3. Dialyzers
8.3.1. High-Flux Dialyzers
8.3.2. Low-Flux Dialyzers
8.4. Machines
8.4.1. Portable Dialysis Machines
8.4.2. Stationary Dialysis Machines
9. Continuous Renal Replacement Therapy Market, by Therapy Type
9.1. Introduction
9.2. Continuous Venovenous Hemodiafiltration (CVVHDF)
9.3. Continuous Venovenous Hemodialysis (CVVHD)
9.4. Continuous Venovenous Hemofiltration (CVVH)
9.5. Slow Continuous Ultrafiltration (SCUF)
10. Continuous Renal Replacement Therapy Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Home Care Settings
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Specialty Clinics
11. Continuous Renal Replacement Therapy Market, by Patient Group
11.1. Introduction
11.2. Adult Patients
11.2.1. Middle Aged
11.2.2. Young Adults
11.3. Geriatric Patients
11.4. Pediatric Patients
11.4.1. Infant
11.4.2. Neonatal
12. Continuous Renal Replacement Therapy Market, by Technology
12.1. Introduction
12.2. Adsorbent Approaches
12.2.1. Recyclable Adsorbents
12.2.2. Single-Use Adsorbents
12.3. Gravity Feed Applications
12.4. High-Efficiency Membranes
12.5. Pump Assisted Continuous Renal Replacement Therapy (PA-CRRT)
13. Continuous Renal Replacement Therapy Market, by Application
13.1. Introduction
13.2. Acute Kidney Injury Management
13.3. Management Of Electrolyte Imbalances
13.4. Multi-Organ Failure
13.5. Septic Shock
14. Continuous Renal Replacement Therapy Market, by Treatment Frequency
14.1. Introduction
14.2. Intermittent Therapy Sessions
14.3. Long-Duration Treatments
14.4. Short-Duration Treatments
15. Continuous Renal Replacement Therapy Market, by Mode Of Service
15.1. Introduction
15.2. Fixed Scheduled Services
15.3. On-Demand Dialysis Services
16. Americas Continuous Renal Replacement Therapy Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Continuous Renal Replacement Therapy Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Anjue Medical Equipment Co., Ltd.
19.3.2. Asahi Kasei Medical Co., Ltd.
19.3.3. B. Braun SE
19.3.4. Baxter International Inc.
19.3.5. Biomedica Medizinprodukte GmbH
19.3.6. Braun & Co. Limited
19.3.7. CytoSorbents Corporation
19.3.8. DIAMED Medizintechnik GmbH
19.3.9. Fresenius Medical Care AG & Co. KGaA
19.3.10. Infomed SA
19.3.11. Joline GmbH & Co. KG
19.3.12. Medites Pharma spol. s.r.o
19.3.13. Medtronic PLC
19.3.14. Miromatrix Medical Inc.
19.3.15. Nextkidney B.V.
19.3.16. Nikkiso Co., Ltd.
19.3.17. Ningbo Tianyi Medical Devices Co., Ltd.
19.3.18. Nipro Corporation
19.3.19. Nuwellis, Inc.
19.3.20. Quanta Dialysis Technologies Limited
19.3.21. SB-KAWASUMI LABORATORIES, INC.
19.3.22. Shionogi & Company, Limited
19.3.23. Sphingotec GmbH
19.3.24. SWS Hemodialysis Care Co. Ltd.
19.3.25. Thermo Fisher Scientific Inc.
19.3.26. Toray Medical Co., Ltd. by Toray Industries, Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET MULTI-CURRENCY
FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET MULTI-LANGUAGE
FIGURE 3. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COMPOSITE MEMBRANES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FLAT PLATE MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOLLOW-FIBER FILTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY LINES AND TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SOLUTION CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HIGH-FLUX DIALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY LOW-FLUX DIALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PORTABLE DIALYSIS MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATIONARY DIALYSIS MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF), BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD), BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH), BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION (SCUF), BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MIDDLE AGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INFANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NEONATAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RECYCLABLE ADSORBENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SINGLE-USE ADSORBENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY GRAVITY FEED APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HIGH-EFFICIENCY MEMBRANES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PUMP ASSISTED CONTINUOUS RENAL REPLACEMENT THERAPY (PA-CRRT), BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACUTE KIDNEY INJURY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MANAGEMENT OF ELECTROLYTE IMBALANCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MULTI-ORGAN FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SEPTIC SHOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INTERMITTENT THERAPY SESSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY LONG-DURATION TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SHORT-DURATION TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FIXED SCHEDULED SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ON-DEMAND DIALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 116. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 118. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 119. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 120. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 121. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 122. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 125. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 126. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 127. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 129. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 131. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 138. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 143. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 145. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 147. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 198. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 200. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 201. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 202. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 203. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 204. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 206. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 207. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 208. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 209. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 211. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 213. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 214. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 216. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 217. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 218. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 219. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 220. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 223. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 224. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 225. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 227. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 229. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 246. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 248. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 249. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 250. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 251. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 252. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 254. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 255. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 256. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 257. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 259. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 261. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADSORBENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 275. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2030 (USD MILLION)
TABLE 277. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODE OF SERVICE, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 280. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY FILTERS AND PRESSURE MONITORS, 2018-2030 (USD MILLION)
TABLE 281. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYZERS, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MACHINES, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PATIENT GROUP, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY

Companies Mentioned

  • Anjue Medical Equipment Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun SE
  • Baxter International Inc.
  • Biomedica Medizinprodukte GmbH
  • Braun & Co. Limited
  • CytoSorbents Corporation
  • DIAMED Medizintechnik GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Infomed SA
  • Joline GmbH & Co. KG
  • Medites Pharma spol. s.r.o
  • Medtronic PLC
  • Miromatrix Medical Inc.
  • Nextkidney B.V.
  • Nikkiso Co., Ltd.
  • Ningbo Tianyi Medical Devices Co., Ltd.
  • Nipro Corporation
  • Nuwellis, Inc.
  • Quanta Dialysis Technologies Limited
  • SB-KAWASUMI LABORATORIES, INC.
  • Shionogi & Company, Limited
  • Sphingotec GmbH
  • SWS Hemodialysis Care Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Toray Medical Co., Ltd. by Toray Industries, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Continuous Renal Replacement Therapy (CRRT) - Global Strategic Business Report - Product Image

Continuous Renal Replacement Therapy (CRRT) - Global Strategic Business Report

  • Report
  • 216 Pages
  • Global
From
Continuous Renal Replacement Therapy Machine Market Report 2025 - Product Image

Continuous Renal Replacement Therapy Machine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Continuous Renal Replacement Therapy Market Report 2025 - Product Image

Continuous Renal Replacement Therapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Continuous Renal Replacement Therapy Machines (CRRT) - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Continuous Renal Replacement Therapy Machines (CRRT) - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Continuous Renal Replacement Therapy Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Continuous Renal Replacement Therapy Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 154 Pages
  • Global
From

About the Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy (CRRT) is a type of dialysis used to treat acute kidney injury (AKI). It is a slow, continuous process that removes waste products and excess fluid from the body. CRRT is used in critically ill patients who are unable to tolerate traditional hemodialysis. It is also used in patients with severe electrolyte imbalances, fluid overload, and acid-base disturbances. CRRT is typically used in intensive care units and can be administered for up to 24 hours a day. CRRT is a growing market, with a variety of companies offering products and services. Some of these companies include Baxter International, Fresenius Medical Care, NxStage Medical, B. Braun Melsungen AG, and Asahi Kasei Medical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.